The patent for Fanapt (iloperidone) currently expires in November 2016. This is the earliest possible date that a generic Fanapt could become available. However, other circumstances (such as lawsuits or other patents for specific Fanapt uses) could come up to extend the exclusivity period beyond that time. It is important to note that iloperidone is the "generic name" for Fanapt; it is not a "generic version" of the drug.
Generic Fanapt: An OverviewFanapt® (iloperidone) is a prescription antipsychotic medication. It is approved for treating schizophrenia.
Fanapt is manufactured by Vanda Pharmaceuticals, Inc. It is currently under the protection of a patent that prevents any generic versions of Fanapt from being manufactured in the United States.